A polymer-based drug delivery system for the antineoplastic agent bis(maltolato)oxovanadium in mice
1997

Polymer-Based Drug Delivery System for Cancer Treatment

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): JK Jackson, W MN, TF Cruz, S Cindric, L Arsenault, DD Von Hoff, D Degan, WL Hunter, HM Burt

Primary Institution: University of British Columbia

Hypothesis

The study investigates the effectiveness of a polymeric drug delivery system for the sustained release of bis(maltolato)oxovanadium (BMOV) as an antineoplastic agent in mice.

Conclusion

The injectable PCL-BMOV formulation effectively releases a chemotherapeutic dose of vanadium for both systemic treatment of tumors and localized treatment of resected tumors.

Supporting Evidence

  • The PCL-BMOV paste showed a concentration-dependent inhibition of tumor growth in mice.
  • 5% BMOV-loaded PCL paste prevented tumor regrowth in resected tumors.
  • Continuous exposure to BMOV was necessary for effective tumor inhibition.

Takeaway

Researchers created a special paste that slowly releases a cancer-fighting drug in mice, helping to stop tumors from growing back after surgery.

Methodology

The study involved in vitro and in vivo experiments using a polymeric paste to deliver BMOV, with drug release and tumor inhibition assessed in mice.

Limitations

The study did not explore the long-term effects of the treatment or the pharmacokinetics of BMOV in detail.

Participant Demographics

The study used male C3H/HeJ and DBA/2j female mice.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication